Dyslipidemia and CVD- part 2 Flashcards
lifestyle mod for dylipidemia
wieght management ( 2-7kg beneficial) and should higher HDL and decrease TG and LDL - PA ( 1200-2200/week) decrease TG by 4-37%, increase HDL and decrease LDL
dominant factor for diet and serum CH
sat fat ( but limitations) - all sat fats not the same and predicts total CH only, not lipid fractions
dietar CH and serum CH
we have responders and non- responders (1/3)
100mg/d decrease in dietary CH results in?
0.05-0.2 mol/L decrease in total CH
how does dietary CH impact blood cholesterol ?
reduced activity of LDL receptors, bc getting CH from the diet and going to the liver, so slow down endogenous making of CH, more in circulation
independent mechanisms of dietary CH
- decreased synth of hepatic LDL receptors,
- more CH in CM–> more atherogenic
- more CH in VLDL and LDL–> more atherogenic
- interferes with ability of HDL to clear CH
high CH foods
shrimp, organ, heart, brain, veal, pork
total fat goal
25-35% total calories ( too low fat may actually decrease HDL)
excess sat fat intake on blood CH/lipoproteins
reduced activity of LDL receptors ( less transcription, alter PL composition (sat fat will link with PL), alter LDL itself (less binding)
goal for sat fat
less than 10%
what do sat fats also increase?
HDL alongside LDL ( so maybe the ratio isn’t so bad) but replace sat fat with MUFA and PUFA
when 5% of energy from sat fat is replaced with PUFA
10% reduction in CVD risk
replace sat fat with carbs?
no benefit on CVD
recommendation for sat fat in canada
no limit, instead focus on health balanced diet
which SFA increase blood LDL
Lauric ( but also increases HDL) myristic, palmitic
MCT effect on serum CH
no effect
SFA from dairy?
neutral effect, not same as SFA from meat
oils with high SFA
coconut oil, butter, palm, beef fat, cocoa butter
Trans FA
increase LDL (same as SFA) but also reduce size of LDL ( more atherogenic)
- reduce HDL
- may increase inflammation markers and endo damage
EPA and DHA come from
18:3w3
effects of omega-6 on blood CH
- passive LDL lowering effect ( removes the suppressing effect of SFA ) so increase clearance of LDL
- may decrease HDL formation ( rare)
goal for omega 6
5-10% calories - too much may cause inflammation
sources of omega 6
corn, sunflower, walnuts, soybean oils
mechanic of the effects of omega 6 on blood CH
inhibition of VLDL production–> less VLDL, less LDL and decrease formation of HDL ( if excess)
MUFA goal
no more than 20%
compared to PUFA, oleic acid __________ but compared to sat fat oleic does ______
does not lower HDL, does lower LDL ( beneficial to sub for sat fats)
advantages of MUFA
doesn’t decrease HDL as PUFAs and carbs do, less susebtable to oxidation as PUFA, don’t increase TG as carbs do, don’t increase cancer risk as PUFA do
benefits of OMEGA 3 in hyperlipidemia patients?
decrease TG. and may reduce the risk of mortality in those with CVD
effects of omega-3 on blood CH
- reduce the amount of TG in VLDL
- prevent coronary thrombosis ( delay proliferation of fibroblasts)
- reduce plaque formation and growth as they reduce the adhesion molecules
- don’t technically lower LDL but replacing them with sat fat would lower
fiber
decrease LDL and total CH
excess carb effect on blood CH
- over production of VLDL-TG (especially if sucrose, fructose)
- decrease HDL
alcohol effects on blood CH
elevates HDL
inhibits acylCoA oxidation in liver: avoid completely if hypertriglyceridemia
soy protein
-reduce TC, LDL and TG
- no effect on HDL
( optimal level not established, 25g may reduce risk of heart disease)
AO
-may inhibit LDL oxidation
hyper-homocysteinemia
greater than 14 umol/L
increase risk of heart disease ( folate and B12 help )
when would supplement folate
patient has high levels or family history of CVD and if B12 def is ruled out)
1st target of treatment
lower LDL
1st step: <10% SFA and < 300mg CH
2nd step: <7 % SFA and < 200 mg CH , weight management and increase PA
factors that increase HDL
sat fat, CH, alcohol, aerobic excersise, estrogens, female sex
factors that decrease HDL levels
simple sugars, high PUFA, obesity, male sex, diabetes, smoking, anabolic steroids
portfolio diet
low in sat fats high in phytosterols, soy and soluble fibers and almonds
drug treatment for hyperlipidemia
- statins
- CH absorption inhibitors
- BAS
- PSCK9
- fibrates
- Nicotinic acid
nicotinic acid
decrease VLDL synthesis and increase LPL activity
average reduction for statins
1.8mmol/L LDL-C: 60% decrease in CVD risks
side effects of statins
myalgia, myopathy, increased liver enzymes ( so need to monitor these annually)
Ezetimibe
decrease intestinal absorption of CH
second line recommendation after statins
ezetimibe
side effects of ezetimibe
diarrhea, rash, fatigue, muscle weakness or pain
BAS
promote sterol excretion ( bind to bile acids in the GI tract so that they will not get reabsorbed) and increase LDL receptors so greater Clarence of VLDL and LDL ( lowers LDL)
side effects of BAS
constipations ( big one)
decrease absorption of fat soluble vitamins, Ca, Fe, Zn, aMG
PCSK9 inhibitors mechanism
PCSK( is an enzyme that helps degrade LDL receptors so that there are less of them, if inhibitor is introduced than less degradation
PCSK9 recommended for
hypercholestrolemia and high LDL-C despite max statin use
side effects of PCSK9
diarrhea, muscle or joint pain, bruising
when are fibrates used?
only for highly elevated TG it is very strong and will decrease TG by 40-50% ( max at 4 weeks) and increase HDL, however it may also increase LDL, it is not recommended in combo with stations for prevention when target has been reached
nicotinic acid
used for primary hypercholesterolemia and hyper tryglyceridemia and hypoalphalipproteinemia
what do fibres do? what other medication has the same effect
decrease VLDL synth and enhance LPL activity
same as nicotinic acid
statin mechanism
block CH synth and increase LDL receptor mediated removal
fibrates side effects
GI reactions and muscle toxicity
nicotinic acid side effects
** only 50-60% of ppl tolerate nicotinic acid !
GI distress and skin itching and hepatotoxicity and skin flushing
contraindications ( reason to with-hold medication) of nicotinic acid
peptic ulcer, hepatic disease, gout, hyperuricemia
contraindications for fibrates
hepatic or renal dysfunction, gallbladder disease
some dietary goals for treatment of severe hyperlipidemia
- ideal body weight
- decrease fat intake , sat fat ( if high cH)
- high TG - limit alcohol, sugars, high carbs
- decrease CH levels
dietary recommendations for dyslipidemia
sat fat <7% poly FA <10% mono <20% total lipids 20-35% CH < 200mg/d carbs - 50--60% protein 15% sterols 2g/d
TLC (dietary approach to dyslipidemia)
low sat fat and low CH, increase PA and weight management